Alzheimer's drugs linked to lower death, heart attack risk

06/5/2013 | MedPage Today (free registration)

Alzheimer's disease patients who took cholinesterase inhibitors to improve cognitive function were 34% less likely to die and experience myocardial infarction than non-users, researchers found. The risk of myocardial infarction was lowest among those who took the highest doses. The study, based on data from more than 7,000 patients in Sweden, was published in the European Heart Journal.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations